NCT02730442View on ClinicalTrials.gov

Study of Potential for Interaction of Fluconazole With F901318

PHASE1CompletedINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

June 30, 2016

Study Completion Date

June 30, 2016

Conditions

Invasive Aspergillosis

Interventions

DRUG

F901318

Administration of F901318 intravenously

DRUG

Fluconazole

Oral administration

Trial Locations (1)

BT9 6AD

CELERION, Belfast

Sponsors

Lead Sponsor

F2G Biotech GmbH

Collaborators (1)

All Listed Sponsors

collaborator

Celerion Ltd

UNKNOWN

lead

F2G Biotech GmbH

INDUSTRY